TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy
Fei Mao, John L. Robinson, Travis L. Unger, Marijan Posavi, Defne A. Amado, Lauren B. Elman, Murray Grossman, David A. Wolk, Edward B. Lee, Vivianna M. Van Deerlin, Sílvia Porta, Virginia M.‐Y. Lee, John Q. Trojanowski, Alice S. Chen‐Plotkin
This study investigates how TMEM106B and C9orf72 genetic variants influence TDP-43 pathology in ALS and FTLD-TDP, finding TMEM106B modifies TDP-43 aggregation severity.
Acta Neuropathologica · Jun 21, 2021Peer-reviewedNeuroscience